Lorcaserin Extended-Release Tablets and Peginterferon alfa-2a Subcutaneous
Determining the interaction of Lorcaserin Extended-Release Tablets and Peginterferon alfa-2a Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: peginterferon alfa-2a
Brand name: Pegasys, Pegasys ProClick Autoinjector, Pegasys Prefilled Syringe
Synonyms: Peginterferon alfa-2a, Peginterferon Alfa-2a
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Peginterferon alfa-2b
- Lorcaserin Extended-Release Tablets-Peginterferon Alfa-2b (Peg-Intron)
- Lorcaserin Extended-Release Tablets-Peginterferon Alfa-2b (Sylatron)
- Lorcaserin Extended-Release Tablets-Peginterferon alfa-2b Subcutaneous
- Lorcaserin Extended-Release Tablets-Peginterferon beta-1a
- Lorcaserin Extended-Release Tablets-Peginterferon beta-1a Subcutaneous
- Peginterferon alfa-2a Subcutaneous-Lorcaserin Hydrochloride
- Peginterferon alfa-2a Subcutaneous-Lorcaserin Tablets
- Peginterferon alfa-2a Subcutaneous-Lorcet
- Peginterferon alfa-2a Subcutaneous-Lorcet Plus
- Peginterferon alfa-2a Subcutaneous-Lorcet Tablets
- Peginterferon alfa-2a Subcutaneous-Lorlatinib